High dose probiotic and prebiotic cotherapy for remission induction of active Crohn’s disease
✍ Scribed by Shunji Fujimori; Atsushi Tatsuguchi; Katya Gudis; Teruyuki Kishida; Keigo Mitsui; Akihito Ehara; Tsuyoshi Kobayashi; Yoshihisa Sekita; Tsuguhiko Seo; Choitsu Sakamoto
- Book ID
- 108951012
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 192 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in
Six adults with refractory acute lymphocytic leukemia (ALL) were treated with high-dose methotrexate, citrovorum factor, and vincristine. All patients had previously received extensive treatment with standard therapeutic agents, including vincristine, and all but one had received prior methotrexate.